131 related articles for article (PubMed ID: 7524795)
21. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
Hou F; Li J; Gao L; Chen Y
Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212
[TBL] [Abstract][Full Text] [Related]
22. Cost efficacy of tazobactam/piperacillin versus imipenem/cilastatin in the treatment of intra-abdominal infection.
Dietrich ES; Schubert B; Ebner W; Daschner F
Pharmacoeconomics; 2001 Jan; 19(1):79-94. PubMed ID: 11252548
[TBL] [Abstract][Full Text] [Related]
23. Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.
Young M; Plosker GL
Pharmacoeconomics; 2001; 19(11):1135-75. PubMed ID: 11735679
[TBL] [Abstract][Full Text] [Related]
24. Piperacillin/tazobactam.
Med Lett Drugs Ther; 1994 Jan; 36(914):7-9. PubMed ID: 8277912
[No Abstract] [Full Text] [Related]
25. A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group.
Eklund AE; Nord CE
J Antimicrob Chemother; 1993 Jan; 31 Suppl A():79-85. PubMed ID: 8383657
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Silvestri C; Di Matteo F; Abbruzzetti A; Scalise G; Saba V
Crit Care Med; 2008 Jan; 36(1):240-5. PubMed ID: 18090372
[TBL] [Abstract][Full Text] [Related]
27. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
28. Ticarcillin/clavulanate compared with clindamycin/gentamicin (with or without ampicillin) for the treatment of intra-abdominal infections in pediatric and adult patients.
Dougherty SH; Sirinek KR; Schauer PR; Fink MP; Fabian TC; Martin DH; Wiedermann B
Am Surg; 1995 Apr; 61(4):297-303. PubMed ID: 7893090
[TBL] [Abstract][Full Text] [Related]
29. Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections.
Brismar B; Malmborg AS; Tunevall G; Wretlind B; Bergman L; Mentzing LO; Nyström PO; Kihlström E; Bäckstrand B; Skau T
Antimicrob Agents Chemother; 1992 Dec; 36(12):2766-73. PubMed ID: 1336347
[TBL] [Abstract][Full Text] [Related]
30. Piperacillin/tazobactam in the treatment of serious acute soft tissue infection.
Gould IM; Ansari A; Harvey G; Douglas JG; Smith CC; Reid TM
Drugs Exp Clin Res; 1991; 17(3):187-90. PubMed ID: 1655374
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of metronidazole and fosfomycin alone and in combination in the treatment of experimentally induced intra-abdominal infections.
Nord CE; Lahnborg G
Scand J Gastroenterol Suppl; 1984; 90():15-9. PubMed ID: 6588479
[TBL] [Abstract][Full Text] [Related]
32. Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate.
Lipsky BA; Giordano P; Choudhri S; Song J
J Antimicrob Chemother; 2007 Aug; 60(2):370-6. PubMed ID: 17553812
[TBL] [Abstract][Full Text] [Related]
33. A randomized controlled trial of ampicillin plus sulbactam vs. gentamicin plus clindamycin in the treatment of intraabdominal infections: a preliminary report. Study Group of Intraabdominal Infections.
Rev Infect Dis; 1986; 8 Suppl 5():S583-8. PubMed ID: 2879345
[TBL] [Abstract][Full Text] [Related]
34. Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study.
Graham DR; Lucasti C; Malafaia O; Nichols RL; Holtom P; Perez NQ; McAdams A; Woods GL; Ceesay TP; Gesser R
Clin Infect Dis; 2002 Jun; 34(11):1460-8. PubMed ID: 12015692
[TBL] [Abstract][Full Text] [Related]
35. Effects of clindamycin and gentamicin and other antimicrobial combinations against enterococci in an experimental model of intra-abdominal abscess.
Willey SH; Hindes RG; Eliopoulos GM; Moellering RC
Surg Gynecol Obstet; 1989 Sep; 169(3):199-202. PubMed ID: 2528215
[TBL] [Abstract][Full Text] [Related]
36. Piperacillin vs gentamicin-clindamycin combination in intra-abdominal infections.
Zissis NP; Mullick RN
J Chemother; 1989 Jul; 1(4 Suppl):818-9. PubMed ID: 16312654
[No Abstract] [Full Text] [Related]
37. In-vitro activity of piperacillin and tazobactam combination against clinically significant bacteria.
Obi CL; Makandiramba B; Robertson V; Tswana SA; Moyo SR; Nziramasanga P
East Afr Med J; 1998 Mar; 75(3):162-5. PubMed ID: 9640815
[TBL] [Abstract][Full Text] [Related]
38. Different antimicrobial agents in treatment and prophylaxis of experimentally induced intraabdominal sepsis.
Lahnborg G; Nord CE
Scand J Gastroenterol Suppl; 1984; 100():10-5. PubMed ID: 6592741
[TBL] [Abstract][Full Text] [Related]
39. Piperacillin and a combination of clindamycin and gentamicin for the treatment of hospital and community acquired acute pelvic infections including pelvic abscess.
Hemsell DL; Hemsell PG; Heard MC; Nobles BJ
Surg Gynecol Obstet; 1987 Sep; 165(3):223-9. PubMed ID: 3306994
[TBL] [Abstract][Full Text] [Related]
40. Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam.
Solomkin J; Teppler H; Graham DR; Gesser RM; Meibohm AR; Roy S; Woods GL
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii51-7. PubMed ID: 15150183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
